Patents by Inventor Vaughan Newcombe

Vaughan Newcombe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11999786
    Abstract: Disclosed herein are antibodies, antigen binding fragments thereof, and antibody drug conjugates thereof that bind human CD48. Also disclosed are pharmaceutical compositions comprising the antibodies, antigen binding fragments thereof, and antibody drug conjugates thereof; and methods of making and using such pharmaceutical compositions for treating cancer in a patient in need of treatment.
    Type: Grant
    Filed: November 23, 2021
    Date of Patent: June 4, 2024
    Assignee: Novartis AG
    Inventors: Joseph Anthony D'Alessio, Claudia Judith Klinter, Cornelia Anne Mundt, Richard Vaughan Newcombe, Tamás Schweighoffer, Katharina Winkelbach
  • Publication number: 20240042051
    Abstract: Anti-CD48 antibody-drug conjugates are disclosed. The anti-CD48 antibody-drug conjugates comprise an Mcl-1 inhibitor drug moiety and an anti-CD48 antibody or antigen-binding fragment thereof that binds an antigen target, e.g., an antigen expressed on a tumor or other cancer cell. The disclosure further relates to methods and compositions for use in the treatment of cancers by administering the antibody-drug conjugates provided herein. Linker-drug conjugates comprising an Mcl-1 inhibitor drug moiety and methods of making same are also disclosed.
    Type: Application
    Filed: November 23, 2021
    Publication date: February 8, 2024
    Inventors: Matthew T. Burger, Zhuoliang Chen, Joseph Anthony D'Alessio, Claudia Judith Klinter, Eric McNeill, Cornelia Anne Mundt, Katsumasa Nakajima, Richard Vaughan Newcombe, Mark G. Palermo, Tamas Schweighoffer, Bing Yu, Katharina Winkelbach, Qiang Zhang, Laura Bresson, Frédéric Colland, Ana Leticia Maragno, Francesca Rocchetti
  • Publication number: 20220162308
    Abstract: Disclosed herein are antibodies, antigen binding fragments thereof, and antibody drug conjugates thereof that bind human CD48. Also disclosed are pharmaceutical compositions comprising the antibodies, antigen binding fragments thereof, and antibody drug conjugates thereof; and methods of making and using such pharmaceutical compositions for treating cancer in a patient in need of treatment.
    Type: Application
    Filed: November 23, 2021
    Publication date: May 26, 2022
    Inventors: Joseph Anthony D'ALESSIO, Claudia Judith KLINTER, Cornelia Anne MUNDT, Richard Vaughan NEWCOMBE, Tamás SCHWEIGHOFFER, Katharina WINKELBACH
  • Publication number: 20060055182
    Abstract: A safety gate assembly includes a frame which may be secured across a door opening, stairway or the like and comprises a base and two upstanding limbs and a gate. One side of the gate is connected by one or more pivotal connections to the one limb of the frame to permit pivotable movement of the gate with respect to the frame about a pivotal axis. The other side of the gate carries a latch member, which cooperates with a latch connected to the other limb of the frame. The latch defines a locked position, in which pivotable movement of the gate is prevented. The pivotal connection is constructed to permit linear movement of the gate relative to the frame in a direction parallel to the pivotal axis. The latch member cooperates with a biasing spring arranged to urge the latch member in the direction away from the said one side of the gate.
    Type: Application
    Filed: September 13, 2005
    Publication date: March 16, 2006
    Applicant: BETTACARE LIMITED
    Inventors: Patrick Jefferys, Vaughan Newcombe